256 patients were randomised to treatment with docetaxel alone (100 mg/ m2 as a 1 hour intravenous infusion every 3 weeks).
256 patsienti said dotsetakseeli (100 mg/ m2 ühetunnine intravenoosne infusioon iga 3 nädala järel) monoteraapiana.